BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 23170167)

  • 41. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
    LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
    Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate Immunity Induces the Accumulation of Lung Mast Cells During Influenza Infection.
    Zarnegar B; Westin A; Evangelidou S; Hallgren J
    Front Immunol; 2018; 9():2288. PubMed ID: 30337928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammasomes as mediators of immunity against influenza virus.
    Pang IK; Iwasaki A
    Trends Immunol; 2011 Jan; 32(1):34-41. PubMed ID: 21147034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Programmed Cell Death in the Pathogenesis of Influenza.
    Fujikura D; Miyazaki T
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30012970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.
    Keef E; Zhang LA; Swigon D; Urbano A; Ermentrout GB; Matuszewski M; Toapanta FR; Ross TM; Parker RS; Clermont G
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
    Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
    PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fueling influenza and the immune response: Implications for metabolic reprogramming during influenza infection and immunometabolism.
    Bahadoran A; Bezavada L; Smallwood HS
    Immunol Rev; 2020 May; 295(1):140-166. PubMed ID: 32320072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Conversation with Dr. Emily Hemann.
    Hemann E
    J Interferon Cytokine Res; 2021 Jul; 41(7):268-269. PubMed ID: 34280027
    [No Abstract]   [Full Text] [Related]  

  • 49. Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection.
    Zhang Y; Xu Z; Cao Y
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32235330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
    Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
    PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memory T Cell Dynamics in the Lung during Influenza Virus Infection.
    Pizzolla A; Wakim LM
    J Immunol; 2019 Jan; 202(2):374-381. PubMed ID: 30617119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host Protective Immune Responses against Influenza A Virus Infection.
    Jung HE; Lee HK
    Viruses; 2020 May; 12(5):. PubMed ID: 32375274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic gene expression analysis in a H1N1 influenza virus mouse pneumonia model.
    Bao Y; Gao Y; Shi Y; Cui X
    Virus Genes; 2017 Jun; 53(3):357-366. PubMed ID: 28243843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome.
    Alymova IV; Cipollo JF; Parsons LM; Music N; Kamal RP; Tzeng WP; Goldsmith CS; Contessa JN; Hartshorn KL; Wilson JR; Zeng H; Gansebom S; York IA
    mBio; 2022 Apr; 13(2):e0298321. PubMed ID: 35285699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Towards a quantitative understanding of the within-host dynamics of influenza A infections.
    Handel A; Longini IM; Antia R
    J R Soc Interface; 2010 Jan; 7(42):35-47. PubMed ID: 19474085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
    Aguilera ER; Lenz LL
    Front Immunol; 2020; 11():105. PubMed ID: 32117259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.
    Hayashi T; MacDonald LA; Takimoto T
    J Virol; 2015 Jun; 89(12):6442-52. PubMed ID: 25855745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigenic evolution of viruses in host populations.
    Rouzine IM; Rozhnova G
    PLoS Pathog; 2018 Sep; 14(9):e1007291. PubMed ID: 30208108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate and adaptive immune responses to viral infection and vaccination.
    Aoshi T; Koyama S; Kobiyama K; Akira S; Ishii KJ
    Curr Opin Virol; 2011 Oct; 1(4):226-32. PubMed ID: 22440781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DAMPs and influenza virus infection in ageing.
    Samy RP; Lim LH
    Ageing Res Rev; 2015 Nov; 24(Pt A):83-97. PubMed ID: 26200296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.